Biogen’s First Pill for Multiple Sclerosis Gains U.S. Approval

Biogen’s First Pill for Multiple Sclerosis Gains U.S. Approval

Neal Hamberg/Bloomberg

A file photo shows people walking by the Biogen Idec Inc. headquarters in Cambridge, Massachusetts during February 2005. Biogen won U.S. approval for its first pill for multiple sclerosis.